![]() |
![]() |
Your cart is empty |
||
Showing 1 - 1 of 1 matches in All Departments
At a time of dramatic increases in the prevalence of obesity, it is
appropriate that Type 2 diabetes has received a great deal of
attention by the endocrinology community. Clearly, the management
of insulin resistance and cardiovascular risk is a critical issue.
However, it is important to also acknowledge and address Type 1
diabetes, whose prevalence is also increasing, and whose management
remains complex. Currently it is estimated that 10-15% of those
with diabetes carry the diagnosis of Type 1 diabetes, and
frequently the diagnosis is not straightforward, as many clinicians
recognize that more adults previously thought to have Type 2
diabetes actually have late-onset Type 1 diabetes (also termed
latent autoimmune diabetes of the adult or LADA). Over the last
decade tools for the management of Type 1 diabetes have also
evolved; therefore, clinicians now have the opportunity to more
closely replicate normal physiologic insulin secretion with either
basal-bolus insulin therapy or continuous subcutaneous insulin
infusions. While these advancements allow clinicians to manage
patients with Type 1 diabetes better, they also add complexity to
patient treatment. An updated text to address the concepts behind
the recognition of new onset Type 1 diabetes in adults, the ongoing
care of adults with established Type 1 diabetes, and future
potential therapies and devices is warranted to review these issues
for both endocrinologists and primary care providers with an
interest in diabetes.
|
![]() ![]() You may like...
Kirstenbosch - A Visitor's Guide
Colin Paterson-Jones, John Winter
Paperback
|